Literature DB >> 8406792

Adherence of Helicobacter pylori to primary human gastrointestinal cells.

M Clyne1, B Drumm.   

Abstract

Helicobacter pylori adheres only to gastric cells in vivo. However, the organism adheres to a wide variety of nongastric cells in vitro. In this study, we have used flow cytometry to assess the adherence of H. pylori to primary epithelial cells isolated from gastric, duodenal, and colonic biopsy specimens by collagenase digestion. After incubation of bacteria and cells together and subsequent staining with a two-stage fluorescein isothiocyanate-labelled H. pylori antibody method, cells with adherent bacteria could be easily distinguished from cells without bacteria. Binding to Kato III cells (a gastric adenocarcinoma cell line) was saturable when bacteria and cells were mixed at a ratio of 250:1. Adherence to cells isolated from gastric biopsy specimens was significantly better than adherence to cells isolated from duodenal or colonic biopsy specimens. Almost 70% of gastric cells had bacteria bound, in contrast to 30% of duodenal cells and 32% of colonic cells (P < 0.0001). There was no correlation between expression of hemagglutinins by the bacteria and ability to bind to either Kato III cells or primary epithelial cells isolated from gastric biopsy specimens. In view of the strict tropism that the organism exhibits in vivo for gastric cells, the results of this study indicate that primary cells are ideal for assessing the factors that might play a role in the pathogenesis of disease caused by the organism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406792      PMCID: PMC281123          DOI: 10.1128/iai.61.10.4051-4057.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Persistence of Helicobacter pylori in conventionalized piglets.

Authors:  K A Eaton; D R Morgan; S Krakowka
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

4.  Campylobacter pylori interactions with gastric cell tissue culture.

Authors:  F A Wyle; A Tarnawski; W Dabros; H Gergely
Journal:  J Clin Gastroenterol       Date:  1990       Impact factor: 3.062

5.  Soluble and cell-associated haemagglutinins of Helicobacter (Campylobacter) pylori.

Authors:  J Robinson; C S Goodwin; M Cooper; V Burke; B J Mee
Journal:  J Med Microbiol       Date:  1990-12       Impact factor: 2.472

6.  Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans.

Authors:  J G Fox; P Correa; N S Taylor; A Lee; G Otto; J C Murphy; R Rose
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

7.  Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children.

Authors:  B Drumm; P Sherman; E Cutz; M Karmali
Journal:  N Engl J Med       Date:  1987-06-18       Impact factor: 91.245

Review 8.  Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

9.  Long-term storage of Campylobacter pylori.

Authors:  B Drumm; P Sherman
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

10.  Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.

Authors:  S L Hazell; A Lee; L Brady; W Hennessy
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

View more
  27 in total

1.  Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.

Authors:  D F Hoft; C S Eickhoff
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  The urease enzyme of Helicobacter pylori does not function as an adhesin.

Authors:  M Clyne; B Drumm
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.

Authors:  M Pantzar; A Ljungh; T Wadström
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

4.  Identification of the N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori.

Authors:  K H Valkonen; T Wadström; A P Moran
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps.

Authors:  N Sakai; M Tatsuta; R Hirasawa; H Iishi; M Baba; Y Yokota; F Ikeda
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

6.  Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease.

Authors:  N Goggin; M Rowland; C Imrie; D Walsh; M Clyne; B Drumm
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

7.  One week treatment for Helicobacter pylori infection.

Authors:  D Walsh; N Goggin; M Rowland; M Durnin; S Moriarty; B Drumm
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

8.  Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.

Authors:  Amna Hashim; Marguerite Clyne; Grace Mulcahy; Donna Akiyoshi; Rachel Chalmers; Billy Bourke
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Helicobacter pylori infection of human and murine primary gastric cells.

Authors:  Marguerite Clyne; Brendan Drumm
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori.

Authors:  K Ogura; M Takahashi; S Maeda; T Ikenoue; F Kanai; H Yoshida; Y Shiratori; K Mori; K I Mafune; M Omata
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.